Skip to main content

Chronic respiratory disease disparity between American Indian/Alaska Native and white populations, 2011–2018

Abstract

Background

American Indian/Alaska Native (AI/AN) populations have been disproportionately affected by chronic respiratory diseases for reasons incompletely understood. Past research into disease disparity using population-based surveys mostly focused on state-specific factors. The present study investigates the independent contributions of AI/AN racial status and other socioeconomic/demographic variables to chronic respiratory disease disparity in an 11-state region with historically high AI/AN representation. Using data from the Behavioral Risk Factor Surveillance System (BRFSS) spanning years 2011–2018, this work provides an updated assessment of disease disparity and potential determinants of respiratory health in AI/AN populations.

Methods

This cross-sectional study used data from the BRFSS survey, 2011–2018. The study population included AI/AN and non-Hispanic white individuals resident in 11 states with increased proportion of AI/AN individuals. The yearly number of respondents averaged 75,029 (62878–87,350) which included approximately 5% AI/AN respondents (4.5–6.3%). We compared the yearly adjusted prevalence for chronic respiratory disease, where disease status was defined by self-reported history of having asthma and/or chronic obstructive pulmonary disease (COPD). Multivariable logistic regression was performed to determine if being AI/AN was independently associated with chronic respiratory disease. Covariates included demographic (age, sex), socioeconomic (marital status, education level, annual household income), and behavioral (smoking, weight morbidity) variables.

Results

The AI/AN population consistently displayed higher adjusted prevalence of chronic respiratory disease compared to the non-Hispanic white population. However, the AI/AN race/ethnicity characteristic was not independently associated with chronic respiratory disease (OR, 0.93; 95% CI, 0.79–1.10 in 2017). In contrast, indicators of low socioeconomic status such as annual household income of <$10,000 (OR, 2.02; 95% CI, 1.64–2.49 in 2017) and having less than high school education (OR, 1.37; 95% CI, 1.16–1.63 in 2017) were positively associated with disease. These trends persisted for all years analyzed.

Conclusions

This study highlighted that AI/AN socioeconomic burdens are key determinants of chronic respiratory disease, in addition to well-established risk factors such as smoking and weight morbidity. Disease disparity experienced by the AI/AN population is therefore likely a symptom of disproportionate socioeconomic challenges they face. Further promotion of public health and social service efforts may be able to improve AI/AN health and decrease this disease disparity.

Peer Review reports

Background

Asthma and chronic obstructive pulmonary disease (COPD) are prominent chronic respiratory conditions that incur significant health and financial costs in the United States [1, 2]. Both diseases entail airflow obstruction and airway inflammation that can progressively worsen and require long-term clinical management [3, 4]. Past surveillance and research efforts have shown the American Indian/Alaska Native (AI/AN) population to suffer a greater prevalence of these conditions [5,6,7]. The health disparities experienced by AI/AN peoples in various chronic diseases including respiratory diseases was shown to be associated with indicators of low socioeconomic status such as poverty [8, 9] and health risk behaviors such as tobacco use [10, 11]. These disease correlates are typically included and hence tracked in population-based surveys such as the Behavioral Risk Factor Surveillance System (BRFSS).

Yet additional correlates of chronic respiratory disease exist which may contribute to disease disparity observed in the AI/AN population. In particular, AI/AN children sustain higher rates of respiratory syncytial virus (RSV) infection [12] which is associated with development and/or exacerbation of asthma [13]. Further, persistent exposure to poor indoor air quality is also increasingly recognized to be associated with adverse respiratory health [14,15,16]. Lastly, AI/AN individuals were more likely to be exposed to occupational inhalants which adversely impact respiratory health [17,18,19]. These variables relate to the etiologies of asthma and COPD and are not included in the BRFSS. Consequently their potential contribution to explain the disease disparity is not known. In this study, we address the contributing influence of race/ethnicity (being AI/AN or non-Hispanic white) on disease status using the most recent multi-year BRFSS data. We hypothesize that if differences in disease etiology are associated with disease prevalence, their effect could be observed as a significant association between the race/ethnicity variable and chronic respiratory disease. Alternatively, if socioeconomic factors are the major drivers of disparity, then AI/AN race/ethnicity will not be independently associated with chronic respiratory disease after adjusting for socioeconomic covariates.

Methods

We used data from the BRFSS survey conducted in the years 2011–2018. The BRFSS is an annual random-digit dialed telephone health survey of adult US residents aged 18 and older [20]. It is conducted across all US states and territories by state health departments in collaboration with the Center for Disease Control and Prevention. In 2017, the AI/AN population was oversampled in 11 states with historically high AI/AN relative populations to increase understanding of their health status [21]. These states were: AK, AZ, MN, MT, NE, NM, NC, ND, OK, SD, and WI. We therefore restricted our analysis to responses from residents of these 11 states. We generated a map showing the locations of these states and their overlap with federally recognized and statistical AI/AN entities by using the open source ‘tigris’ package [22] in R version 3.6.1. The shapefile containing the geographic information of these federally recognized AI/AN entities used for map plotting was obtained from the US Census Bureau [23]. The analysis of publicly available, de-identified data does not constitute human subjects research as defined in federal regulations, and thus this study did not require Institutional Review Board (IRB) review.

The primary outcome, chronic respiratory disease status, was dichotomized as Negative if respondents gave 0 affirmative answers for the following questions or as Positive if they gave at least 1 affirmative answer: ‘Have you ever been told you had asthma’ and ‘Have you ever been told you have chronic obstructive pulmonary disease, COPD, emphysema, or chronic bronchitis?’ The exposure variable, race, included AI/AN or non-Hispanic White (hereafter termed White) as indicated by the BRFSS computed race variable. Respondents of other races were not included in the analysis. The number of responses analyzed per year averaged 75,029 (62878–87,350) which included approximately 5% AI/AN respondents (4.5–6.3%).

Demographic, socioeconomic, and behavioral variables were included as covariates in the analysis. Demographic covariates with their respective levels included: sex (male, female); age (18–24, 25–34, 35–44, 45–54, 55–64, 65 and older). Socioeconomic covariates included marital status (currently married, never married, formerly married); education level (some high school and lower, high school graduate, some college, college graduate); annual household income (<$10,000, $10,000 - < $15,000, $15,000 - < $20,000, $20,000 - < $25,000, $25,000 - < $35,000, $35,000 - < $50,000, $50,000 - < $75,000, ≥$75,000, unreported income); and access-to-care (adequate, inadequate). Behavioral covariates included smoking status (smoker, non-smoker); and weight morbidity as defined by body mass index (BMI) (underweight, normal weight, overweight, obese). Access-to-care was a composite variable aimed to assess both healthcare access and utilization. It was dichotomized as Inadequate if respondents gave 0–1 favorable answers for the following questions or as Adequate if they gave ≥2 favorable answers: ‘Do you have any kind of health care coverage, including health insurance, prepaid plans such as HMOs, or government plans such as Medicare, or Indian Health Service?’, ‘Do you have one person you think of as your personal doctor or health care provider?’, and ‘Was there a time in the past 12 months when you needed to see a doctor but could not because of cost?’ Respondents were categorized as smokers if they gave a positive answer to either of the questions: “Have you smoked at least 100 cigarettes in your entire life?”, and “Do you now smoke cigarettes every day, some days, or not at all?”

Responses with missing values for any variables except annual household income were excluded from analysis. Due to a substantial proportion of responses with missing annual household income, this variable could not be assumed as missing at random. We therefore assigned these responses to an “unreported income” category and included it as a level during regression.

Bivariable and multivariable logistic regression analyses were performed on individual years of BRFSS data from 2011 to 2018. Rao-Scott χ2 test was used to test for statistical difference between categorical variables. 2-tailed p values < .05 are considered statistically significant. To select for significant covariates for the logistic regression models, a stepwise forward modeling process was used. Odds ratios indicate associations when confidence intervals (CI) exclude 1.

To account for the complex sampling design of the BRFSS, data analysis was performed with the survey package [24] using R version 3.6.1. Specifically, the yearly adjusted prevalence of chronic respiratory disease with 95% CI for AI/AN or white populations was calculated using yearly survey weights available as part of the BRFSS data.

Results

Prevalence of chronic respiratory disease

In 2017, oversampling for AI/AN respondents was done in 11 states identified by the US government as having historically higher AI/AN relative populations (Fig. 1A). Indeed, consistently for each year included in this study (2011–2018), about half of the US AI/AN population was resident in this 11-state group [25, 26]. To assess potential disparity in chronic respiratory disease status between AI/AN and white populations, we calculated the yearly weighted disease prevalence for 2011–2018. In each year except 2015, the AI/AN population was observed to have higher disease prevalence than the white population (Fig. 1B).

Fig. 1
figure1

The AI/AN population experiences higher prevalence of chronic respiratory disease. A Location of federally recognized and statistical American Indian and Alaska Native entities in blue, including reservations. States included in this study are labeled with two-letter abbreviation and were oversampled in 2017 due to historically increased AI/AN representation. The map shown was produced using the tigris package [22] in R with shapefiles publicly available from the US Census Bureau [23]. B Adjusted prevalence of chronic respiratory disease in AI/AN and non-Hispanic white respondents surveyed in years 2011–2018. Comparisons between AI/AN vs white are statistically significant by χ2 test for all years except 2015

Determinants of chronic respiratory disease

To assess if being AI/AN contributed to having chronic respiratory disease, and to identify significant determinants of disease we performed logistic regression analysis. We present detailed results for 2017 when oversampling of the AI/AN population was undertaken but similar trends were found for other years. Among the 71,939 respondents included in the analysis of the 2017 data, 4501 (6.3%) respondents were AI/AN (Table 1). To select for covariates used in multivariable logistic regression, we included variables which were statistically different between healthy respondents and respondents with disease (Rao-Scott X2, p < 0.05). Being AI/AN was found to be not associated with chronic respiratory disease (OR, 0.93; 95% CI, 0.79–1.10) in multivariable logistic regression analysis after adjusting for covariates. By contrast, a number of behavioral and socioeconomic factors are positively associated with disease. Behavioral factors included being a smoker (OR, 1.72; 95% CI, 1.55–1.90) and being obese (OR, 1.40; 95% CI, 1.29–1.52). Socioeconomic determinants included having less than high school education (OR, 1.37; 95% CI, 1.16–1.63) and low income levels. Annual household income was generally inversely correlated with odds of having chronic respiratory disease ($35,000- < $50,000: OR, 1.27; 95% CI, 1.12–1.45; $25000- < $35,000: OR, 1.26; 95% CI, 1.09–1.45; $20000- < $25,000: OR, 1.43; 95% CI, 1.22–1.68; $15000- < $20,000: OR, 1.87; 95% CI, 1.57–2.24; $10000- < $15,000: OR, 2.29; 95% CI, 1.89–2.78; <$10,000: OR, 2.02; 95% CI, 1.64–2.49) (Fig. 2 and Additional File 1). Logistic regression was also performed on data from years 2011–2018 except 2015, when the adjusted prevalence of chronic respiratory disease was found to be not statistically different between AI/AN and white populations. We found race to be not associated with chronic respiratory disease in any survey year (Table 2) while significant covariates remained broadly the same (Additional File 1).

Table 1 Characteristics of analyzed control respondents and respondents with chronic respiratory disease (CRD) in 2017 BRFSS
Fig. 2
figure2

Determinants of chronic respiratory disease. Odds ratios with 95% CI are calculated from logistic regression performed on data from survey year 2017 for the 11 oversampled states. The AI/AN variable is not associated with chronic respiratory disease. Only significant covariates are shown. For covariates, closed circles represent variables negatively associated with disease. Open circles indicate variables positively associated with disease. Bars represent 95% CI. Reference levels for covariates are indicated in Table 1

Table 2 Association between race and chronic respiratory disease for 2011–2018

Discussion

In this cross-sectional analysis using annual BRFSS surveys spanning 2011–2018, we observed higher prevalence of chronic respiratory disease in AI/AN respondents compared to non-Hispanic white respondents, and sought to characterize factors contributing to this disparity.

We found that being AI/AN was not independently associated with chronic respiratory disease. Adjusting for sociodemographic and behavioral covariates equalized the odds ratios for chronic respiratory disease between AI/AN and white populations. By contrast, socioeconomic factors such as low annual household income and educational attainment were strong determinants of chronic respiratory disease status. These findings were consistent for almost all years included in the analysis despite 2017 being the only year when the AI/AN population was oversampled. The exception was 2015 when the AI/AN sample could have been too small to reach statistical significance. Regardless, these consistent observations underscored the importance of low socioeconomic status in determining chronic respiratory disease status [27, 28], while further showing that the AI/AN characteristic retained no disparity after accounting for these covariates. These data also validate the effectiveness of such public health surveillance effort in capturing critical disease correlates.

Why might AI/AN people exhibit higher prevalence of chronic respiratory disease? It has been well documented that a greater proportion of AI/AN people live in poverty compared to other races. In the most recent 5-year estimate (2014–2018) from the American Community survey, the median household income for the AI/AN population was $41,879 compared to $60,293 for the nation as a whole [29]. In the same period, 25.8% of AI/AN people lived below poverty level compared to 14.1% of the general population [30]. AI/AN levels of education attainment similarly lag behind that of other races [31] and AI/AN high school graduation rate was found to be lowest among all races/ethnicities [32]. Smoking prevalence was also highest for the AI/AN group compared to other race/ethnicities [33, 34]. The increased proportion of AI/AN people with low socioeconomic status is worrying. Low socioeconomic status has been consistently shown to be associated with worse disease outcome for both COPD [28, 35, 36] and asthma [37, 38],

In summary, our findings confirm that the AI/AN population still exhibits higher prevalence of chronic respiratory disease compared to the non-Hispanic white population. Positive disease covariates include established socioeconomic variables while the AI/AN racial characteristic is not independently associated with disease. Our study therefore recommends that efforts to further promote cooperative mobilization of public health and social service infrastructures may make progress to address this disease disparity.

Strengths and limitations

Our study leveraged the oversampled data of the AI/AN population in the 2017 BRFSS to gain insight into the disparity of chronic respiratory disease. Despite 2017 being the only year with oversampling, our finding was consistent for all 7 years of the BRFSS where the AI/AN sample was found to be sufficient. However, we acknowledge a number of limitations in this study. Due to the cross-sectional nature of the BRFSS survey, temporal relationships and causality relationships of determinants cannot be established, some of which may also be bidirectional. This study relied on self-reported data in regards to health-risk behavior (smoking), disease status, and race classification. These types of self-classification might include nonrandom misclassification, and can present a limitation to the study, such as when self-reported smoking underestimates true smoking behavior [39]. However, some studies suggest that self-reported rates of smoking are generally reliable for large national US surveys [40, 41], and the present study confirms the expected observation that smoking status is positively associated with chronic respiratory disease. For self-reported asthma and COPD status, previous research has demonstrated general concordance between self-reported status and clinical diagnosis using spirometry [42, 43]. Lastly, our analysis was limited to covariates available from the BRFSS survey, which may fail to capture all confounders, some of which could be ethnoculturally unique to the AI/AN population.

Conclusions

This study found that in the most recent years of the BRFSS, the AI/AN population experienced chronic respiratory disease disparity compared to the non-Hispanic white population. However, the AI/AN racial characteristic was not independently associated with disease status. This suggests that disproportionate socioeconomic challenges continue to exist for the AI/AN population. Our study therefore recommends cooperative mobilization of public health and social service infrastructures to address disease disparity.

Availability of data and materials

Annual BRFSS data is publicly available at: https://www.cdc.gov/brfss/annual_data/annual_data.htm

Abbreviations

AI/AN:

American Indian/Alaska Native

BRFSS:

Behavior Risk Factor Surveillance System

CI:

Confidence Interval

COPD:

Chronic Obstructive Pulmonary Disease

OR:

Odds Ratio

References

  1. 1.

    Nurmagambetov T, Kuwahara R, Garbe P. The Economic Burden of Asthma in the United States, 2008–2013. Ann Am Thorac Soc. 2018;15(3):348–56.

    Article  Google Scholar 

  2. 2.

    May SM, Li JTC. Burden of chronic obstructive pulmonary disease: healthcare costs and beyond. Allergy asthma proc. 2015;36(1):4–10.

    Article  Google Scholar 

  3. 3.

    National Asthma Education and Prevention Program. Expert panel report III: Guidelines for the diagnosis and management of asthma. Bethesda: National Heart, Lung, and Blood Institute; 2007. (NIH publication no. 08–4051). https://www.nhlbi.nih.gov/health-topics/guidelines-for-diagnosis-management-of-asthma. Accessed: Mar 28, 2020

    Google Scholar 

  4. 4.

    Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Pulmonary Disease: 2020 Report. https://www.goldcopd.org. Accessed 28 Mar 2020.

  5. 5.

    Gorman BK, Chu M. Racial and ethnic differences in adult asthma prevalence, problems, and medical care. Ethn Health. 2009;14(5):527–52.

    Article  Google Scholar 

  6. 6.

    Ospina MB, Voaklander DC, Stickland MK, King M, Senthilselvan A, Rowe BH. Prevalence of asthma and chronic obstructive pulmonary disease in Aboriginal and non-Aboriginal populations: a systematic review and meta-analysis of epidemiological studies. Can Respir J. 2012;19(6):355–60. https://doi.org/10.1155/2012/825107.

    Article  PubMed  PubMed Central  Google Scholar 

  7. 7.

    Ford ES, Croft JB, Mannino DM, Wheaton AG, Zhang X, Giles WH. COPD surveillance--United States, 1999-2011. Chest. 2013;144(1):284–305. https://doi.org/10.1378/chest.13-0809.

    Article  PubMed  PubMed Central  Google Scholar 

  8. 8.

    Cockerham WC, Hamby BW, Oates GR. The Social Determinants of Chronic Disease. Am J Prev Med. 2017;52(1S1):S5–S12.

    Article  Google Scholar 

  9. 9.

    Sarche M, Spicer P. Poverty and health disparities for American Indian and Alaska Native children: current knowledge and future prospects. Ann N Y Acad Sci. 2008;1136(1):126–36.

    Article  Google Scholar 

  10. 10.

    Polosa R, Thomson NC. Smoking and asthma: dangerous liaisons. Eur Respir J. 2013;41(3):716–26. https://doi.org/10.1183/09031936.00073312.

    CAS  Article  PubMed  Google Scholar 

  11. 11.

    Laniado-Laborín R. Smoking and chronic obstructive pulmonary disease (COPD). Parallel epidemics of the 21 century. Int J Environ Res Public Health. 2009;6(1):209–24.

    Article  Google Scholar 

  12. 12.

    Basnayake TL, Morgan LC, Respirology AC. The global burden of respiratory infections in indigenous children and adults: a review. Respirology. 2017;22(8):1518–28.

    Article  Google Scholar 

  13. 13.

    Driscoll AJ, Arshad SH, Bont L, Brunwasser SM, Cherian T, Englund JA, et al. Does respiratory syncytial virus lower respiratory illness in early life cause recurrent wheeze of early childhood and asthma? Critical review of the evidence and guidance for future studies from a World Health Organization-sponsored meeting. Vaccine. 2020;38(11):2435–48. https://doi.org/10.1016/j.vaccine.2020.01.020.

    Article  PubMed  PubMed Central  Google Scholar 

  14. 14.

    Bunnell JE, Garcia LV, Furst JM, Lerch H, Olea RA, Suitt SE, et al. Navajo coal combustion and respiratory health near Shiprock, New Mexico. J Environ Public Health. 2010;2010(5):260525–14.

    PubMed  PubMed Central  Google Scholar 

  15. 15.

    Mortimer K, Gordon SB, Jindal SK, Accinelli RA, Balmes J, Martin WJ. Household air pollution is a major avoidable risk factor for cardiorespiratory disease. Chest. 2012;142(5):1308–15. https://doi.org/10.1378/chest.12-1596.

    Article  PubMed  PubMed Central  Google Scholar 

  16. 16.

    Lowe AA, Bender B, Liu AH, Solomon T, Kobernick A, Morgan W, et al. Environmental concerns for children with asthma on the Navajo nation. Ann Am Thorac Soc. 2018;15(6):745–53. https://doi.org/10.1513/AnnalsATS.201708-674PS.

    Article  PubMed  PubMed Central  Google Scholar 

  17. 17.

    Redwood D, Lanier AP, Brubaker M, Orell L, Tom-Orme L, George C, et al. Occupational and environmental exposures among Alaska Native and American Indian people living in Alaska and the Southwest United States. J Environ Health. 2012;74(9):22–8.

    PubMed  Google Scholar 

  18. 18.

    Trupin L, Earnest G, San Pedro M, Balmes JR, Eisner MD, Yelin E, et al. The occupational burden of chronic obstructive pulmonary disease. Eur Respir J. 2003;22(3):462–9. https://doi.org/10.1183/09031936.03.00094203.

    CAS  Article  PubMed  Google Scholar 

  19. 19.

    Tarlo SM, Lemiere C. Occupational asthma. N Engl J Med. 2014;370(7):640–9.

    CAS  Article  Google Scholar 

  20. 20.

    Centers for Disease Control and Prevention. Behavioral Risk Factor Surveillance System. https://www.cdc.gov/brfss/. Accessed 3 Jan 2020.

  21. 21.

    Office of Minority Health. BRFSS Oversampling Study. https://minorityhealth.hhs.gov/omh/browse.aspx?lvl=2&lvlid=89/. Accessed 3 Jan 2020.

  22. 22.

    Walker KE. tigris: An R Package to Access and Work with Geographic Data from the US Census Bureau. R J R Project. 2016.

  23. 23.

    U.S. Census Bureau. 2019 TIGER/line shapefiles: American Indian area geography. https://wwwcensusgov/cgi-bin/geo/shapefiles/indexphp?year=2019&layergroup=American+Indian+Area+Geography/. Accessed 3 Jan 2020.

  24. 24.

    Lumley T. Analysis of complex survey samples. J Stat Softw. 2004;9(8).

  25. 25.

    U.S. Census Bureau. Table B01001C: SEX BY AGE (AMERICAN INDIAN AND ALASKA NATIVE ALONE). 2011–2015 American Community Survey 5-Year Estimates; 2015.

  26. 26.

    U.S. Census Bureau. Table B01001C: SEX BY AGE (AMERICAN INDIAN AND ALASKA NATIVE ALONE). 2014–2018 American Community Survey 5-Year Estimates; 2018.

  27. 27.

    Williams DR, Sternthal M, Wright RJ. Social determinants: Taking the social context of asthma seriously. Pediatrics. 2009;123(SUPPL. 3):S174–84.

    Article  Google Scholar 

  28. 28.

    Pleasants RA, Riley IL, Mannino DM. Defining and targeting health disparities in chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2016;11(1):2475–96.

    Article  Google Scholar 

  29. 29.

    U.S. Census Bureau. Table B19013C and B19013: Median Household Income in the Past 12 Months. 2014–2018 American Community Survey 5-Year Estimates; 2018.

  30. 30.

    U.S. Census Bureau. Table B17001C and B17001: Poverty Status in the Past 12 Months by Sex by Age. 2014–2018 American Community Survey 5-Year Estimates; 2018.

  31. 31.

    DeVoe JF, Darling-Churchill KE, Snyder TD. Status and trends in the education of American Indians and Alaska Native: 2008 (NCES 2008–084). Washington, DC: National Center for Education Statistics. US Department of Education; 2008.

    Google Scholar 

  32. 32.

    Faircloth SC, Tippeconnic JW III. The Dropout/Graduation Rate Crisis Among American Indian and Alaska Native Students: Failure to Respond Places the Future of Native Peoples at Risk. Los Angeles: The Civil Rights Project Proyecto Derechos Civiles at UCLA; 2010. www.civilrightsproject.ucla.edu/ Accessed Jan 3, 2020

    Google Scholar 

  33. 33.

    Drope J, Liber AC, Cahn Z, Stoklosa M, Kennedy R, Douglas CE, et al. Who’s still smoking? Disparities in adult cigarette smoking prevalence in the United States. CA Cancer J Clin. 2018;68(2):106–15.

    Article  Google Scholar 

  34. 34.

    National Center for Health Statistics. Health, United States, 2018. Hyattsville, Maryland; 2019. Available from: https://wwwcdcgov/nchs/data/hus/2018/019pdf/. Accessed 22 Sept 2020.

  35. 35.

    Steenland K, Hu S, Walker J. All-cause and cause-specific mortality by socioeconomic status among employed persons in 27 US states, 1984–1997. Am J Public Health. 2004;94(6):1037–42.

    Article  Google Scholar 

  36. 36.

    Lewis DR, Clegg LX, Johnson NJ. Lung disease mortality in the United States: the National Longitudinal Mortality Study. Int J Tuberc Lung Dis. 2009;13(8):1008–14.

    CAS  PubMed  Google Scholar 

  37. 37.

    Trupin L, Katz PP, Balmes JR, Chen H, Yelin EH, Omachi T, et al. Mediators of the socioeconomic gradient in outcomes of adult asthma and rhinitis. Am J Public Health. 2013;103(2):e31–8.

    Article  Google Scholar 

  38. 38.

    Forno E, Celedon JC. Asthma and ethnic minorities: socioeconomic status and beyond. Curr Opin Allergy Clin Immunol. 2009;9(2):154–60.

    Article  Google Scholar 

  39. 39.

    Connor Gorber S, Schofield-Hurwitz S, Hardt J, Levasseur G, Tremblay M. The accuracy of self-reported smoking: a systematic review of the relationship between self-reported and cotinine-assessed smoking status. Nicotine Tob Res. 2009;11(1):12–24. https://doi.org/10.1093/ntr/ntn010.

    Article  PubMed  Google Scholar 

  40. 40.

    West R, Zatonski W, Przewozniak K, Jarvis MJ. Can we trust national smoking prevalence figures? Discrepancies between biochemically assessed and self-reported smoking rates in three countries. Cancer Epidemiol Biomark Prev. 2007;16(4):820–2.

    Article  Google Scholar 

  41. 41.

    Yeager DS, Krosnick JA. The validity of self-reported nicotine product use in the 2001-2008 National Health and nutrition examination survey. Med Care. 2010;48(12):1128–32. https://doi.org/10.1097/MLR.0b013e3181ef9948.

    Article  PubMed  Google Scholar 

  42. 42.

    Barr RG, Herbstman J, Speizer FE, Camargo CA. Validation of self-reported chronic obstructive pulmonary disease in a cohort study of nurses. Am J Epidemiol. 2002;155(10):965–71. https://doi.org/10.1093/aje/155.10.965.

    Article  PubMed  Google Scholar 

  43. 43.

    Kauppi P, Laitinen LA, Laitinen H, Kere J, Laitinen T. Verification of self-reported asthma and allergy in subjects and their family members volunteering for gene mapping studies. Respir Med. 1998;92(11):1281–8. https://doi.org/10.1016/S0954-6111(98)90229-3.

    CAS  Article  PubMed  Google Scholar 

Download references

Acknowledgements

We thank Chi-Ren Shyu, PhD, for mentorship and training in Data Science.

Funding

KGL and AGS were funded by the Intersect Fellowship for Computational Scientists and Immunologists (American Association of Immunologists). It provided salary support for KGL.

Author information

Affiliations

Authors

Contributions

KGL conceived the project, performed data analysis, and wrote the manuscript. KGL and AGS jointly designed the study. KGL, ADN, MJL, QN, and AGS interpreted the data. ADN, AGS and LRS edited the manuscript. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Kimberly G. Laffey.

Ethics declarations

Ethics approval and consent to participate

The analysis of publicly available, de-identified data does not constitute human subjects research as defined in federal regulations, and thus this study did not require Institutional Review Board (IRB) review.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Additional file 1.

Determinants of chronic respiratory disease for 2011–2018. This table lists detailed covariates and odds ratios obtained from logistic regression analyses for years 2011 through 2018.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Laffey, K.G., Nelson, A.D., Laffey, M.J. et al. Chronic respiratory disease disparity between American Indian/Alaska Native and white populations, 2011–2018. BMC Public Health 21, 1466 (2021). https://doi.org/10.1186/s12889-021-11528-8

Download citation

Keywords

  • BRFSS
  • American Indian/Alaskan Native
  • Chronic respiratory disease
  • Health disparities